An announcement from CalciMedica (CALC) is now available.
CalciMedica, Inc. stockholders convened for the 2024 Annual Meeting, endorsing a key amendment to increase the authorized stock issuance under the company’s 2023 Equity Incentive Plan by 1.5 million shares. Additionally, they elected two Class I directors for a three-year term and ratified the appointment of Moss Adams LLP as the principal independent auditor for the upcoming fiscal year. These decisions reflect shareholders’ active participation in shaping the company’s strategic incentives and governance.
Learn more about CALC stock on TipRanks’ Stock Analysis page.
